Hope for tardive dyskinesia: tetrabenazine put to the test
NCT ID NCT01543321
First seen Nov 19, 2025 · Last updated May 21, 2026 · Updated 22 times
Summary
This study tested the drug tetrabenazine (Xenazine) in 54 adults with tardive dyskinesia, a condition causing uncontrollable movements after long-term antipsychotic use. The goal was to see if the drug could reduce these movements better than a placebo over 10 weeks. The approach was a double-blind, placebo-controlled trial to confirm if tetrabenazine is effective and safe for managing this often-irreversible side effect.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for TARDIVE DYSKINESIA are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
AP-HM Hopital de la Timone
Marseille, 13385, France
-
CH Aix en Provence
Aix-en-Provence, 13100, France
-
CH des Charpennes
Lyon, 69100, France
-
CHRU Lille
Lille, 59037, France
-
CHRU de Nimes
Nîmes, 30900, France
-
CHU Amiens
Amiens, Picardie, 80000, France
-
CHU Bordeaux
Bordeaux, 33076, France
-
CHU Caen
Caen, 14033, France
-
CHU Clermont-Ferrand
Clermont-Ferrand, 63003, France
-
CHU Limoges
Limoges, 87042, France
-
CHU Montpellier
Montpellier, 34295, France
-
CHU Nantes
Nantes, 44093, France
-
CHU Nice
Nice, 06002, France
-
CHU Poitiers
Poitiers, 86021, France
-
CHU Rouen
Rouen, 76031, France
-
CHU Saint Antoine
Paris, 75012, France
-
CHU Strasbourg
Strasbourg, 67091, France
-
CHU Toulouse
Toulouse, 31059, France
-
CHU de Rennes
Rennes, 35033, France
Conditions
Explore the condition pages connected to this study.